Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Modification of radiation response.

H D Suit

    International Journal of Radiation Oncology, Biology, Physics
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Radiation response modifiers improve cancer treatment by targeting tumor cells. Identifying patient indicators for modifier efficacy is crucial for personalized radiation therapy strategies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Protons to replace photons in external beam radiation therapy?

    Clinical oncology (Royal College of Radiologists (Great Britain))·2003
    Same author

    Predictive value of histologic tumor necrosis after radiation.

    International journal of cancer·2001
    Same author

    Endothelial cells and radiation gastrointestinal syndrome.

    Science (New York, N.Y.)·2001
    Same author

    Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma.

    International journal of radiation oncology, biology, physics·2001
    Same author

    Vascular endothelial growth factor receptor-2-blocking antibody potentiates radiation-induced long-term control of human tumor xenografts.

    Cancer research·2001
    Same author

    Anti-Vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions.

    Cancer research·2000

    Area of Science:

    • Radiation oncology
    • Medical physics
    • Clinical pharmacology

    Background:

    • Radiation response modifiers alter tissue response to radiation.
    • Assessing the clinical value of these modifiers presents significant challenges.
    • Heterogeneity in clinical material is a major obstacle for testing response modifiers.

    Purpose of the Study:

    • To review efforts in assessing clinical value of radiation response modifiers.
    • To identify major problems in clinical testing of these modifiers.
    • To explore potential for stratifying patients for targeted modifier application.

    Main Methods:

    • Review of existing literature on radiation response modifiers.
    • Analysis of challenges in clinical trials for response modifiers.

    Related Experiment Videos

  • Discussion of laboratory and clinical investigation areas for patient stratification.

    • Main Results:

    • Clinical material heterogeneity is a significant, undefined problem.
    • Identifying patient indicators for response modifier benefit has large potential.
    • Past disappointing results (e.g., misonidazole) should not halt testing of new sensitizers.

    Conclusions:

    • Further clinical trials are needed to verify findings on radiation response modifiers.
    • Stratification of patients based on hypoxia or reoxygenation is essential.
    • New trials of pyrimidine analogs and emphasis on topical/regional radiation protectors are warranted.